Related references
Note: Only part of the references are listed.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
Chih-Cheng Lai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Presumed Asymptomatic Carrier Transmission of COVID-19
Yan Bai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The reproductive number of COVID-19 is higher compared to SARS coronavirus
Ying Liu et al.
JOURNAL OF TRAVEL MEDICINE (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
What we know so far: COVID-19 current clinical knowledge and research
Mary A. Lake
CLINICAL MEDICINE (2020)
Update: Public Health Response to the Coronavirus Disease 2019 Outbreak — United States, February 24, 2020
Daniel B. Jernigan et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor
Nathani Minaz et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Molecular Docking and In Silico Cogitation Validate Mefenamic Acid Prodrugs as Human Cyclooxygenase-2 Inhibitor
Kamal Shah et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2019)
Drug Repurposing Approach for Developing Novel Therapy Against Mupirocin-Resistant Staphylococcus aureus
Somdutt Mujwar et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2019)
Prediction of Riboswitch as a Potential Drug Target for Infectious Diseases: An lnsilico Case Study of Anthrax
Somdutt Mujwar et al.
JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS (2015)
Multiple organ infection and the pathogenesis of SARS
J Gu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
